课题基金 / 基金详情

IN VIVO ANALYSIS OF INTRACELLULAR SIGNALS CONTROLLING LYMPHOCYTE

IN VIVO ANALYSIS OF INTRACELLULAR SIGNALS CONTROLLING LYMPHOCYTE
控制淋巴细胞的细胞内信号的体内分析
批准号:
6288940
负责人:
Hua Gu
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

Hua Gu的其他基金

相似基金

相关文献

中文摘要
翻译
虽然T细胞抗原受体(TCR)和其他共受体传递的信号在早期T细胞发育中起着至关重要的作用,但这些信号是如何在细胞内调节的仍有待阐明。我们已经确定原癌蛋白Cbl是TCR信号的负调节因子,并在胸腺选择过程中生理调节TCR信号阈值。这些结果首次证明,原癌蛋白Cbl在生理上有助于小鼠胸腺选择和功能性T细胞群的建立。同时检测活化的T细胞及其在体内的运动在技术上是困难的。我们已经建立了一个报告小鼠系,其中激活的产生IL-2的T细胞可以很容易地通过插入IL-2基因位点的GFP标记来监测。该小鼠模型为我们提供了一种强大的方法来非破坏性地鉴定产生IL-2的T细胞,并在体外和体内跟踪其随后的分化命运。- TCR信号,接头分子,Cbl,胸腺选择,T细胞发育,IL-2基因表达,GFP报告基因,基因靶向。
英文摘要
While signals delivered by the T cell antigen receptor (TCR) and other co-receptors play an essential role for early T cell development, it remains to be clarified as to how are these signals modulated intracellularly. We have identified that the proto-oncoprotein Cbl is a negative regulator for TCR signaling, and physiologically regulates the TCR signalling threshold during thymic selection. These results provide first evidence that proto-onco protein Cbl physiologically contributes to the thymic selection and establishment of the functional T cell population in mice. It has been technically difficult to simultaneously detect the activated T cells and their movement in vivo. We have established a reporter mouse line in which the activated IL-2 producing T cells can be readily monitored by a GFP marker inserted into its IL-2 gene locus. This mouse model provides us a powerful approach to non- destructively identify IL-2 producing T cells and follow their subsequent differentiation fate both in vitro and in vivo. - TCR signaling, adaptor molecule, Cbl, thymic selection, T cell development, IL-2 gene expression, GFP reporter, gene targeting.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Adenoisen-PKA signaling axis in Treg development and homeostasis
Role of PKA in autoimmune diabetes through dendritic cells (DC) and regulatory T
Cbl Mediated Ubiquitination in Autoimmunity
CbI mediated ubiquitination in autoimmunity Systemic Lupus Erythematosus (SLE)
海外基金